UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 8-K


CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934


Date of Report (Date of earliest event reported): February 1, 2011


POSITIVEID CORPORATION

(Exact name of registrant as specified in its charter)


 

 

 

 

 

DELAWARE

 

001-33297

 

06-1637809

  

 

  

 

 

(State or other Jurisdiction
of Incorporation)

 

(Commission File Number)

 

(IRS Employer Identification No.)


1690 SOUTH CONGRESS AVENUE, SUITE 200

 

 

DELRAY BEACH, FLORIDA

 

33445

  

 

 

(Address of Principal Executive Offices)

 

(Zip Code)


Registrant’s telephone number, including area code: 561-805-8008


                                                                                                            

(Former name or former address if changed since last report.)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

 

 

o

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 

 

o

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 

 

o

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 

 

o

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))




 

Item 5.02   Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.


On February 1, 2011, the Board of Directors of PositiveID Corporation, a Delaware corporation (the “Company”), appointed Ned L. Siegel to serve as a member of the Company’s Board of Directors. Mr. Siegel has not yet been appointed to any committee of the Board.


Mr. Siegel, in exchange for consulting services provided to the Company in 2010, received 50,000 shares of the Company’s common stock on each of January 4, 2010 and July 7, 2010, worth $55,500 and $46,000, respectively, based on the closing price of a share of the Company’s common stock on the grant dates.




2




SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


PositiveID Corporation



Date: February 4, 2011


/s/ William J. Caragol                           

William J. Caragol 

President and Chief Financial Officer 



3